<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Stadler, Julia-Christina</style></author><author><style face="normal" font="default" size="100%">Keller, Laura</style></author><author><style face="normal" font="default" size="100%">Mess, Christian</style></author><author><style face="normal" font="default" size="100%">Bauer, Alexander T</style></author><author><style face="normal" font="default" size="100%">Koett, Julian</style></author><author><style face="normal" font="default" size="100%">Geidel, Glenn</style></author><author><style face="normal" font="default" size="100%">Heidrich, Isabel</style></author><author><style face="normal" font="default" size="100%">Vidal-y-Sy, Sabine</style></author><author><style face="normal" font="default" size="100%">Andreas, Antje</style></author><author><style face="normal" font="default" size="100%">Stramaglia, Carlotta</style></author><author><style face="normal" font="default" size="100%">Sementsov, Mark</style></author><author><style face="normal" font="default" size="100%">Haberstroh, Wiebcke</style></author><author><style face="normal" font="default" size="100%">Deitert, Benjamin</style></author><author><style face="normal" font="default" size="100%">Hoehne, Inka Lilott</style></author><author><style face="normal" font="default" size="100%">Reschke, Robin</style></author><author><style face="normal" font="default" size="100%">Haalck, Thomas</style></author><author><style face="normal" font="default" size="100%">Pantel, Klaus</style></author><author><style face="normal" font="default" size="100%">Gebhardt, Christoffer</style></author><author><style face="normal" font="default" size="100%">Schneider, Stefan W</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors</style></title><secondary-title><style face="normal" font="default" size="100%">Journal for ImmunoTherapy of Cancer</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2023-05-01 00:00:00</style></date></pub-dates></dates><elocation-id><style  face="normal" font="default" size="100%">e006456</style></elocation-id><doi><style  face="normal" font="default" size="100%">10.1136/jitc-2022-006456</style></doi><volume><style face="normal" font="default" size="100%">11</style></volume><issue><style face="normal" font="default" size="100%">5</style></issue><abstract><style  face="normal" font="default" size="100%">Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.</style></abstract></record></records></xml>